Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 42 Gastrointestinal 40 Head & Neck 11 Thoracic 10 Gynecologic 9 Other hematologic neoplasm 8 Tumor-Agnostic 7 Genitourinary 6 Lymphoid 4 Endocrine 3 Sarcoma 2 CNS 2 Plasma cell 1 Other solid neoplasm 1 Other neoplasm 1 Other 1 NET 1 Dermatologic 1 Classical hematology 1

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

Exercise 27 Metformin 24 Methods 14 Radiotherapy 13 Early Intervention, Educational 13 Educational Status 12 Counseling 12 Surveys and Questionnaires 10 Standard of Care 10 Nutrition Assessment 9 Resistance Training 8 Diet Therapy 8 Cisplatin 8 naloxegol 7 Tirzepatide 7 Diet 7 alvimopan 6 Psychiatric Rehabilitation 6 Fibroblast Growth Factor 7 6 Caloric Restriction 6 Radiation 5 Low-Level Light Therapy 5 Liraglutide 5 Injections 5 Exenatide 5 Dexamethasone 5 Cryotherapy 5 semaglutide 4 angiotensin I (1-7) 4 Vitamin D 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Control Groups × Other × Clear all

NCT01150539 2021-08-25

POLY

Pennington Biomedical Research Center

Phase NA Completed

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡